The Effects of Normalizing Blood Pressure on Cerebral Blood Flow in Hypotensive Individuals With Spinal Cord Injury

Trial Profile

The Effects of Normalizing Blood Pressure on Cerebral Blood Flow in Hypotensive Individuals With Spinal Cord Injury

Recruiting
Phase of Trial: Phase II

Latest Information Update: 25 Jan 2018

At a glance

  • Drugs Midodrine (Primary) ; Mirabegron (Primary) ; Pyridostigmine (Primary)
  • Indications Orthostatic hypotension; Spinal cord injuries
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2019.
    • 18 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2019.
    • 27 Dec 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top